MicroTech Medical (Hangzhou) Co (HKSE:02235) Change In Receivables : HK$-25.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Change In Receivables?

MicroTech Medical (Hangzhou) Co's change in receivables for the quarter that ended in Dec. 2023 was HK$0.0 Mil. It means MicroTech Medical (Hangzhou) Co's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

MicroTech Medical (Hangzhou) Co's change in receivables for the fiscal year that ended in Dec. 2023 was HK$-29.7 Mil. It means MicroTech Medical (Hangzhou) Co's Accounts Receivable increased by HK$29.7 Mil from Dec. 2022 to Dec. 2023 .

MicroTech Medical (Hangzhou) Co's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$80.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. MicroTech Medical (Hangzhou) Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 97.18.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. MicroTech Medical (Hangzhou) Co's liquidation value for the six months ended in Dec. 2023 was HK$2,044.7 Mil.

MicroTech Medical (Hangzhou) Co Change In Receivables Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Change In Receivables Chart

MicroTech Medical (Hangzhou) Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-3.31

-4.20

-22.82

-19.55

-29.74

MicroTech Medical (Hangzhou) Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial			-16.20	-1.60	-25.49	-	-

MicroTech Medical (Hangzhou) Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-25.5 Mil.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

MicroTech Medical (Hangzhou) Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	80.102	/	150.43	*	91
=	97.18

2. In Ben Graham's calculation of liquidation value, MicroTech Medical (Hangzhou) Co's accounts receivable are only considered to be worth 75% of book value:

MicroTech Medical (Hangzhou) Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2068.418	-	106.859	+	0.75 * 80.102	+	0.5 * 46.064
=	2,044.7

MicroTech Medical (Hangzhou) Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.microtechmd.com

MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.

Executives

Zheng Pan
Master Summer Limited	2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd	2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p.	2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p.	2201 Interest of corporation controlled by you
Cdbi Gp, Ltd	2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p.	2201 Interest of corporation controlled by you
Cd Capital Gp Ltd	2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp V, L.p.	2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p.	2201 Interest of corporation controlled by you
Qm32 Limited	2101 Beneficial owner
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited	2101 Beneficial owner

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines